Multiple Award Schedule

Deadline: 27 May 2029

United States

Ref. No.: 5883619

EMD:Ref Document

Bid Value: Ref Document

1095 Days Left

Open House Original Discount Agreements 2024 04 Cariprazine

Deadline: 30 Jun 2026

Germany

Ref. No.: 5776321

EMD:Ref Document

Bid Value: Ref Document

33 Days Left

Open House Discount Contracts 2024 07

Deadline: 30 Jun 2026

Germany

Ref. No.: 5653458

EMD:Ref Document

Bid Value: Ref Document

33 Days Left

Open House Biologics Discount Agreements 2024 02 Romiplostim

Deadline: 30 Jun 2026

Germany

Ref. No.: 5604853

EMD:Ref Document

Bid Value: Ref Document

33 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5599069

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Open House Biologics Discount Agreements 2024 03 Omalizumab

Deadline: 30 Jun 2026

Germany

Ref. No.: 5598331

EMD:Ref Document

Bid Value: Ref Document

33 Days Left

Openhouse Procedure Various Active Pharmaceutical Ingredients From October 1St 2024

Deadline: 05 Aug 2026

Germany

Ref. No.: 5597729

EMD:Ref Document

Bid Value: Ref Document

69 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5485044

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5460438

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5457173

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5450913

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5266211

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Open House Discount Contracts 2024 06

Deadline: 31 May 2026

Germany

Ref. No.: 5145136

EMD:Ref Document

Bid Value: Ref Document

3 Days Left

Multiple Award Schedule

Deadline: 14 Apr 2029

United States

Ref. No.: 5048492

EMD:Ref Document

Bid Value: Ref Document

1052 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Octreotide Atc Code According To Who H01Cb02

Deadline: 31 May 2026

Germany

Ref. No.: 5038643

EMD:Ref Document

Bid Value: Ref Document

3 Days Left

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

FREE Trial plan for all new users!